Newton, MA, United States of America

Mark W Kieran

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Other. Active years: 2016-2024.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal2 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark W Kieran: Innovator in Combination Therapies

Introduction

Mark W Kieran is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of medicine, particularly in the development of combination therapies for various diseases. With a total of 3 patents, Kieran's work focuses on addressing complex health issues through innovative approaches.

Latest Patents

Kieran's latest patents include groundbreaking therapies aimed at treating laminopathies, cellular aging, and atherosclerosis. These combination therapies are designed to target progeroid diseases and conditions, cellular aging, bone diseases, and cardiovascular diseases. The therapies specifically address the aberrant farnesylation of the mutant lamin A protein progerin, enhancing progerin clearance and offering new hope for patients suffering from these conditions.

Career Highlights

Throughout his career, Kieran has demonstrated a commitment to advancing medical science. His innovative approaches have positioned him as a leader in the field of combination therapies. His work not only contributes to scientific knowledge but also has the potential to improve patient outcomes significantly.

Collaborations

Kieran has collaborated with esteemed colleagues, including Leslie B Gordon and Monica E Kleinman. These partnerships have fostered a collaborative environment that enhances the development of effective therapies.

Conclusion

Mark W Kieran's contributions to the field of medicine through his innovative combination therapies highlight his dedication to improving health outcomes. His work continues to inspire advancements in the treatment of complex diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…